All Type of News
Conspicuous sales rise for Celebrex
Pfizer's Celebrex gained a majority of sales for new-generation painkillers last year amid growing safety concerns over popular Gevorin and other acetaminophen drugs, according to Ubist market data.
Last year, sale...
Pharmaceutical firms mull smart work
Pharmaceutical companies are considering making a big push for “smart work,” while closing their branch offices - working away from the traditional office using the latest information technology products
The push f...
Scientists claim brain tumor drug possible
A group of Korean researchers claimed Monday that they found a way to use drugs to fight brain tumors that are currently treated with only surgery and chemotherapy.
The researchers, led by POSTEC chemistry professo...
New homegrown antimalarial drug to be approved in first half
The Korea Food and Drug Administration is likely to approve Pyramax, an investigational antimalarial medicine developed by Shinpoong Pharmaceutical Co, possibly in the first half of this year.
Pyramax is a fixed-do...
New homegrown antimalarial drug to be approved in first half
The Korea Food and Drug Administration is likely to approve Pyramax, an investigational antimalarial medicine developed by Shinpoong Pharmaceutical Co, possibly in the first half of this year.
Pyramax is a fixed-do...
Boehringer Ingelheim's Pradaxa to garner bigger sales in Korea
Pradaxa (dabigatran etexilate), which was approved by the Korea Food and Drug Administration on February 18, will hit the domestic blood thinning products market, according to market experts.
Pradaxa is an anticoag...
KFDA restricts use of buflomedil preparations
The Korea Food and Drug Administration said recently that it imposes new restrictions on the use of a vasodilator buflomedil in an effort to protect patients from the risks of neurological and heart problems.
The a...
Cataract patients show 1.6-fold increase in 7 years
The National Health Insurance Corporation (NHIC) says the number of patients being treated for cataract has increased by 1.6 times over the past seven years.
In 2009, 775,000 people had their cataract treatment cov...
Zydena takes on Viagra, Cialis
Dong-A Pharmaceutical, Korea’s No. 1 drug maker, is enjoying brisk sales of its new anti-impotence drug, Zydena.
Sales of Dong-A’s erectile dysfunction medicine reached over 80 billion won (equivalent to 10 millio...
Green Cross emerges as No. 2 drugmaker
The local pharmaceutical industry is undergoing a major change in the reshuffle of the leader board of drug manufacturers.
Dong-A Pharmaceutical kept its number 1 ranking in terms of revenue for over four decades, ...
